Do Novel Biomarkers Have Utility in the Diagnosis and Prognosis of AKI? PRO

Kellum, John A.; Goldstein, Stuart L.

doi:10.34067/kid.0000000000000189

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Do Novel Biomarkers Have Utility in the Diagnosis and Prognosis of AKI? PRO

Abstract: This article will present the pro-side of debate concerning the utility of novel biomarkers in the diagnosis and prognosis of AKI.

Cited by 3 publications

References 31 publications

Sepsis-Associated Acute Kidney Injury

Sepsis-Associated Acute Kidney Injury

Derivation and Validation of an Optimal Neutrophil Gelatinase-Associated Lipocalin Cutoff to Predict Stage 2/3 Acute Kidney Injury (AKI) in Critically Ill Children

Are biomarkers in acute kidney injury ready for prime time? The time is right for a second look

Contact Info

Product

Resources

About